Familial Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Familial Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-11-30Clinical Trial Update: Familial Hypercholesterolemia Amongst Patients With Acute Coronary Syndrome
An ongoing clinical trial evaluating familial hypercholesterolemia in patients with acute coronary syndrome; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Aortic Stenosis in Subjects With Heterozygous Familial Hypercholesterolemia on Prolonged Treatment With Statins
Clinical trial update regarding aortic stenosis in subjects with heterozygous familial hypercholesterolemia on prolonged statin therapy. The…
-
FDA label_change · 2017-08-04FDA Approved: LESCOL XL — Supplemental Application (Sandoz Inc)
FDA is reviewing a supplemental application for LESCOL XL (fluvastatin sodium) from Sandoz Inc., likely involving changes to the product lab…
-
FDA approval · 2017-08-04FDA Approved: LOVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for Lovastatin (generic statin). The approval pertains to changes under the AND…
-
FDA label_change · 2017-07-27FDA Approved: PRALUENT — Supplemental Application (Regeneron Pharmaceuticals, Inc.)
The FDA approved a supplemental application for PRALUENT (alirocumab) from Regeneron Pharmaceuticals to update the drug's labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-07-11FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for pravastatin sodium (a generic statin product).
-
FDA approval · 2017-06-12FDA Approved: EZETIMIBE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s original application for ezetimibe, a generic cholesterol-lowering medication.
-
FDA approval · 2017-06-12FDA Approved: EZETIMIBE — Original Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a generic ezetimibe tablet from Quallent Pharmaceuticals Health LLC under ANDA204331. Ezetimibe lowers cholesterol and is u…
-
CLINICAL_TRIALS research · 2017-05-15Clinical Trial Update: A Registration Study for Familial Hypercholesterolemia in Taiwan
A registration study for familial hypercholesterolemia in Taiwan is noted, with the current status not disclosed. The entry appears to be an…
-
FDA approval · 2017-04-24FDA Approved: PRALUENT — Supplemental Application (Regeneron Pharmaceuticals, Inc.)
The FDA approved a supplemental application for PRALUENT (alirocumab) submitted by Regeneron Pharmaceuticals, Inc., updating the product’s l…
-
FDA approval · 2017-03-27FDA Approved: ATORVASTATIN CALCIUM — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's atorvastatin calcium as an original-application generic product.
-
FDA approval · 2017-01-25FDA Approved: REPATHA — Supplemental Application (Amgen USA Inc.)
The FDA page indicates a supplemental application for Repatha (evolocumab) submitted by Amgen USA Inc.; the submission status is AP.
-
FDA approval · 2017-01-19FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC.
-
FDA approval · 2017-01-03FDA Approved: REPATHA — Supplemental Application (Amgen USA Inc.)
FDA approved a supplemental application for REPATHA (evolocumab) submitted by Amgen USA Inc.
-
FDA approval · 2016-11-20FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pravastatin sodium from Aurobindo Pharma Limited (ANDA077793), authorizing continued marketing o…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for rosuvastatin as a generic product. Rosuvastatin is used to treat hyperlipidemia an…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved an Original Application for rosuvastatin calcium from Torrent Pharmaceuticals Limited, granting generic approval for the rosuva…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves rosuvastatin (generic) under an Original Application by Camber Pharmaceuticals, adding a generic statin option for lowering cho…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN CALCIUM — Original Application (PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS)
FDA approved an original ANDA for rosuvastatin calcium, enabling a generic version of rosuvastatin calcium manufactured by Puracap Laborator…
-
CLINICAL_TRIALS withdrawal · 2016-09-23Clinical Trial Update: Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients [Phase 2]
The Phase 2 trial evaluating APL180 on endothelial function in familial hypercholesterolemia patients has been withdrawn.
-
CLINICAL_TRIALS research · 2016-08-16Clinical Trial Update: Developing and Implementing Familial Hypercholesterolemia Registry
A clinical trial registry update describing the development and implementation of a Familial Hypercholesterolemia registry.
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy [Phase 2]
A Phase 2 dose-escalation safety study evaluating ISIS 301012 in patients with familial hypercholesterolemia on lipid-lowering therapy has c…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy [Phase 2]
A phase 2 trial of mipomersen in patients with familial hypercholesterolemia on lipid-lowering therapy has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Postprandial Response After Intake of Meals With Different Fatty Acid Composition [NA]
A completed University of Oslo study evaluated postprandial lipid and metabolic responses after meals with different fatty acid compositions…
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Detection of Familial Hypercholesterolaemia in Cardiovascular Disease Registry
A completed registry update from University College London evaluates the detection of Familial Hypercholesterolemia in patients with cardiov…